Genomic strategies for personalized cancer therapy

被引:37
作者
Garman, Katherine S. [1 ]
Nevins, Joseph R. [1 ]
Potti, Anil [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA
关键词
D O I
10.1093/hmg/ddm184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Numerous recent studies have demonstrated the use of genomic data, particularly gene expression signatures, as clinical prognostic factors in cancer and other complex diseases. These studies highlight the opportunity for strategies to achieve truly personalized cancer treatment. In particular, the ability to develop gene expression signatures will likely allow us to guide the use of currently available cancer drugs, develop new targeted therapeutics, and provide an opportunity to better match the most effective drug or drugs with the molecular characteristics of the individual patient.
引用
收藏
页码:R226 / R232
页数:7
相关论文
共 36 条
  • [11] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
    Druker, Brian J.
    Guilhot, Francois
    O'Brien, Stephen G.
    Gathmann, Insa
    Kantarjian, Hagop
    Gattermann, Norbert
    Deininger, Michael W. N.
    Silver, Richard T.
    Goldman, John M.
    Stone, Richard M.
    Cervantes, Francisco
    Hochhaus, Andreas
    Powell, Bayard L.
    Gabrilove, Janice L.
    Rousselot, Philippe
    Reiffers, Josy
    Cornelissen, Jan J.
    Hughes, Timothy
    Agis, Hermine
    Fischer, Thomas
    Verhoef, Gregor
    Shepherd, John
    Saglio, Giuseppe
    Gratwohl, Alois
    Nielsen, Johan L.
    Radich, Jerald P.
    Simonsson, Bengt
    Taylor, Kerry
    Baccarani, Michele
    So, Charlene
    Letvak, Laurie
    Larson, Richard A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) : 2408 - 2417
  • [12] ETTINGER DS, 2006, J NATL COMPR CANC NA, V6, P548
  • [13] Converting a breast cancer microarray signature into a high-throughput diagnostic test
    Glas, Annuska M.
    Floore, Arno
    Delahaye, Leonie J. M. J.
    Witteveen, Anke T.
    Pover, Rob C. F.
    Bakx, Niels
    Lahti-Domenici, Jaana S. T.
    Bruinsma, Tako J.
    Warmoes, Marc O.
    Bernards, Rene
    Wessels, Lodewyk F. A.
    Van 't Veer, Laura J.
    [J]. BMC GENOMICS, 2006, 7 (1)
  • [14] Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
    Golub, TR
    Slonim, DK
    Tamayo, P
    Huard, C
    Gaasenbeek, M
    Mesirov, JP
    Coller, H
    Loh, ML
    Downing, JR
    Caligiuri, MA
    Bloomfield, CD
    Lander, ES
    [J]. SCIENCE, 1999, 286 (5439) : 531 - 537
  • [15] Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: Results from the prostate cancer outcomes study
    Graff, Julie N.
    Mori, Motomi
    Li, Hong
    Garzotto, Mark
    Penson, David
    Potosky, Arnold L.
    Beer, Tomasz M.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04) : 1307 - 1312
  • [16] GREENE EL, 2002, AJCC CANC STAGING MA
  • [17] Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
    Györffy, B
    Surowiak, P
    Kiesslich, O
    Denkert, C
    Schäfer, R
    Dietel, M
    Lage, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) : 1699 - 1712
  • [18] Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
    Hess, Kenneth R.
    Anderson, Keith
    Symmans, W. Fraser
    Valero, Vicente
    Ibrahim, Nuhad
    Mejia, Jaime A.
    Booser, Daniel
    Theriault, Richard L.
    Buzdar, Aman U.
    Dempsey, Peter J.
    Rouzier, Roman
    Sneige, Nour
    Ross, Jeffrey S.
    Vidaurre, Tatiana
    Gomez, Henry L.
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) : 4236 - 4244
  • [19] Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
    Holleman, A
    Cheok, MH
    den Boer, ML
    Yang, WJ
    Veerman, AJP
    Kazemier, KM
    Pei, DQ
    Cheng, C
    Pui, CH
    Relling, MV
    Janka-Schaub, GE
    Pieters, R
    Evans, WE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) : 533 - 542
  • [20] Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
    Huang, Fei
    Reeves, Karen
    Han, Xia
    Fairchild, Craig
    Platero, Suso
    Wong, Tai W.
    Lee, Francis
    Shaw, Peter
    Clark, Edwin
    [J]. CANCER RESEARCH, 2007, 67 (05) : 2226 - 2238